BIOMAT Database Logo BIOMAT Database Logo

HER-2/neu oncogene sequence revisited. 2002

Franco M Venanzi, and Laura Soverchia, and Paola Felicetti, and Milena Mennecozzi, and Antonio Concetti

UI MeSH Term Description Entries
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D003596 Cytosine A pyrimidine base that is a fundamental unit of nucleic acids.
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016133 Polymerase Chain Reaction In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships. Anchored PCR,Inverse PCR,Nested PCR,PCR,Anchored Polymerase Chain Reaction,Inverse Polymerase Chain Reaction,Nested Polymerase Chain Reaction,PCR, Anchored,PCR, Inverse,PCR, Nested,Polymerase Chain Reactions,Reaction, Polymerase Chain,Reactions, Polymerase Chain
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats
D017353 Gene Deletion A genetic rearrangement through loss of segments of DNA or RNA, bringing sequences which are normally separated into close proximity. This deletion may be detected using cytogenetic techniques and can also be inferred from the phenotype, indicating a deletion at one specific locus. Deletion, Gene,Deletions, Gene,Gene Deletions

Related Publications

Franco M Venanzi, and Laura Soverchia, and Paola Felicetti, and Milena Mennecozzi, and Antonio Concetti
Amplification of Her-2/neu oncogene in GERD - Barrett's metaplasia – dysplasia - adenocarcinoma sequence.
January 2013, Hepato-gastroenterology,
Franco M Venanzi, and Laura Soverchia, and Paola Felicetti, and Milena Mennecozzi, and Antonio Concetti
HER-2/neu oncogene: what does amplification mean?
July 1993, British journal of cancer,
Franco M Venanzi, and Laura Soverchia, and Paola Felicetti, and Milena Mennecozzi, and Antonio Concetti
Transcriptional targeting of the HER-2/neu oncogene.
December 2000, Drugs of today (Barcelona, Spain : 1998),
Franco M Venanzi, and Laura Soverchia, and Paola Felicetti, and Milena Mennecozzi, and Antonio Concetti
HER-2/neu oncogene expression in advanced breast cancer.
January 2001, Cancer detection and prevention,
Franco M Venanzi, and Laura Soverchia, and Paola Felicetti, and Milena Mennecozzi, and Antonio Concetti
HER-2/neu oncogene in uterine carcinosarcoma on tamoxifen therapy.
January 2005, Pathology, research and practice,
Franco M Venanzi, and Laura Soverchia, and Paola Felicetti, and Milena Mennecozzi, and Antonio Concetti
Amplification of HER-2/neu oncogene in human ovarian cancer.
November 1992, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society,
Franco M Venanzi, and Laura Soverchia, and Paola Felicetti, and Milena Mennecozzi, and Antonio Concetti
Overexpression of the HER-2/neu oncogene in pancreatic adenocarcinoma.
October 2001, American journal of clinical oncology,
Franco M Venanzi, and Laura Soverchia, and Paola Felicetti, and Milena Mennecozzi, and Antonio Concetti
HER-2/neu oncogene protein and prognosis in breast cancer.
August 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Franco M Venanzi, and Laura Soverchia, and Paola Felicetti, and Milena Mennecozzi, and Antonio Concetti
Gastrinomas demonstrate amplification of the HER-2/neu proto-oncogene.
June 1994, Annals of surgery,
Franco M Venanzi, and Laura Soverchia, and Paola Felicetti, and Milena Mennecozzi, and Antonio Concetti
[HER-2/neu oncogene as prognostic factor in breast carcinoma].
January 1992, Pathologica,
Copied contents to your clipboard!